Literature DB >> 1429206

Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.

S Ono1, Y Kurata, Y Shichino, M Sano, S Fukushima.   

Abstract

Synergistic or additive effects of combined treatments with carcinogens or promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-initiated rat bladder carcinogenesis were examined. Male F344 rats were given BBN as an initiator followed by low doses of 3 sodium salts (sodium bicarbonate, sodium L-ascorbate and sodium citrate) and/or 3 antioxidants (butylated hydroxyanisole, butylated hydroxytoluene and tertiary butylhydroxyquinone). Combined treatments with 3 sodium salts or 3 antioxidants, and especially all 6 chemicals together promoted bladder carcinogenesis. In addition, these combined treatments were associated with increased DNA synthesis of the bladder epithelium. Combined administration of the carcinogens, o-anisidine, p-cresidine, and 4-chloro-o-phenylenediamine at low doses also enhanced BBN-initiated bladder carcinogenesis. These results indicate that environmental carcinogens or promoters can exert synergistic or additive actions on bladder cancer induction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429206      PMCID: PMC5918976          DOI: 10.1111/j.1349-7006.1992.tb02007.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


N‐butyl‐N‐(4‐hydroxy‐butyl)nitrosamine sodium L‐ascorbate sodium citrate butylated hydroxyanisole butylated hydroxytoluene tertiary butylhydroxyquinone 4‐chloro‐ck‐phenylenediamine 5‐bromo‐2′‐deoxyuridine prostaglandin E2 basement membrane papillary or nodular
  45 in total

Review 1.  Promotion of urinary bladder carcinogenesis in experimental animals.

Authors:  N Ito; S Fukushima
Journal:  Exp Pathol       Date:  1989

2.  Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer.

Authors:  A Danon; T V Zenser; D L Thomasson; B B Davis
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

3.  Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.

Authors:  H Tsuda; Y Miyata; G Murasaki; H Kinoshita; S Fukushima
Journal:  Gan       Date:  1977-04

4.  Sodium citrate: a promoter of bladder carcinogenesis.

Authors:  S Fukushima; W Thamavit; Y Kurata; N Ito
Journal:  Jpn J Cancer Res       Date:  1986-01

Review 5.  Strategy for detection of cancer hazards to man.

Authors:  R Doll
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

Review 6.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

7.  Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.

Authors:  S Fukushima; G Murasaki; M Hirose; K Nakanishi; R Hasegawa; N Ito
Journal:  Acta Pathol Jpn       Date:  1982-03

8.  L-isoleucine and L-leucine: tumor promoters of bladder cancer in rats.

Authors:  Y Nishio; T Kakizoe; M Ohtani; S Sato; T Sugimura; S Fukushima
Journal:  Science       Date:  1986-02-21       Impact factor: 47.728

9.  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.

Authors:  N Ito; S Fukushima; S Tamano; M Hirose; A Hagiwara
Journal:  J Natl Cancer Inst       Date:  1986-12       Impact factor: 13.506

10.  Combination effects of forty carcinogens administered at low doses to male rats.

Authors:  S Takayama; H Hasegawa; H Ohgaki
Journal:  Jpn J Cancer Res       Date:  1989-08
View more
  1 in total

1.  Evolution on experimental animal model for upper urothelium carcinogenesis.

Authors:  Leonardo O Reis; Wagner J Fávaro; Ubirajara Ferreira; Athanase Billis; Mariana G Fazuoli; Valéria H A Cagnon
Journal:  World J Urol       Date:  2010-04-06       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.